Fougera Receives Approval For First Generic Sulfacetamide Sodium Topical Suspension USP 10% (Rx)

... Specialty pharmaceutical manufacturer Fougera, a division of ALTANA Inc, announced today that it has received FDA approval to bring to market the first generic Sulfacetamide Sodium Topical Suspension USP 10% (Rx). The generic formulation compares to KLARON(R) by Dermik, whose patent has expired. The market for the brand name product was approximately $25 million in 2005. [click link for full article] ...